• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[低剂量链激酶诱发脑出血:药理学悖论?1例临床病例报告]

[Cerebral hemorrhage induced by low-dose streptokinase: a pharmacologic paradox? Report of a clinical case].

作者信息

Fedeli F, Skouse D, Messina A

机构信息

Divisione di Cardiologia-UCC, Azienda Ospedaliera E. Morelli, Sondalo, Sondrio.

出版信息

Minerva Cardioangiol. 1997 Jul-Aug;45(7-8):377-81.

PMID:9463173
Abstract

A case of an important intracranial hemorrhage after a low dose (approx. 500,000 UI) of streptokinase in a 60 year-old woman suffering from myocardial infarction is presented. Clinical, electrocardiographic, echocardiographic, lab and tomographic findings are described. The authors suggest a pharmacokinetic mechanism which could be responsible of a "paradox effect" (a powerful and dangerous effect of the drug when given in low dose) and they wonder whether in case of allergic reactions should it be better not to stop the infusion of the thrombolytic drug and be more liberal with the "symptomatic" drugs. Tha patient is still alive and the clinical conditions slowly progressing.

摘要

本文报道了一例60岁患有心肌梗死的女性在接受低剂量(约500,000国际单位)链激酶治疗后发生重要颅内出血的病例。描述了临床、心电图、超声心动图、实验室及断层扫描检查结果。作者提出了一种药代动力学机制,该机制可能导致“矛盾效应”(药物低剂量使用时产生的强大且危险的效应),他们还探讨了在发生过敏反应时,是否最好不要停止溶栓药物输注,而应更自由地使用“对症”药物。患者仍然存活,临床状况正在缓慢进展。

相似文献

1
[Cerebral hemorrhage induced by low-dose streptokinase: a pharmacologic paradox? Report of a clinical case].[低剂量链激酶诱发脑出血:药理学悖论?1例临床病例报告]
Minerva Cardioangiol. 1997 Jul-Aug;45(7-8):377-81.
2
Successful outcome after evacuation of intracranial hematoma following thrombolysis in acute myocardial infarction.急性心肌梗死溶栓治疗后颅内血肿清除术后的成功预后。
Saudi Med J. 2005 Jan;26(1):130-2.
3
Severe backache during thrombolytic therapy with streptokinase.
J Assoc Physicians India. 1996 Oct;44(10):743.
4
[Intracerebral hemorrhage and serum sickness after thrombolytic treatment in myocardial infarction].[心肌梗死溶栓治疗后发生脑出血和血清病]
Lakartidningen. 1991 Sep 18;88(38):3069-70.
5
A comparative study of intravenous accelerated streptokinase dose regimen with conventional dose regimen for coronary thrombolysis.静脉注射加速链激酶剂量方案与常规剂量方案用于冠状动脉溶栓的对比研究。
Chin Med J (Engl). 1997 Jan;110(1):59-61.
6
Coronary thrombolysis: hemorrhagic complications.冠状动脉溶栓:出血并发症。
Can J Cardiol. 1993 Jul-Aug;9(6):505-11.
7
Two diagnoses from one electrocardiogram.一份心电图得出两项诊断结果。
Postgrad Med J. 2001 Sep;77(911):604, 612-3. doi: 10.1136/pmj.77.911.604.
8
Pericardial effusion after streptokinase for acute myocardial infarction: an echocardiographic 1-year follow-up study.
Cardiology. 1997 Nov-Dec;88(6):544-7. doi: 10.1159/000177417.
9
Efficacy of a new accelerated streptokinase regime in acute myocardial infarction: a double blind randomized clinical trial.新的加速链激酶方案治疗急性心肌梗死的疗效:一项双盲随机临床试验。
Cardiovasc Ther. 2013 Feb;31(1):53-9. doi: 10.1111/j.1755-5922.2011.00284.x. Epub 2011 Aug 4.
10
Intracerebral hemorrhage after combined anticoagulant-thrombolytic therapy for myocardial infarction: two case reports and a short review.
Neurosurgery. 1992 Jun;30(6):943-5. doi: 10.1227/00006123-199206000-00025.